Nijman HW - Search Results

1

Development of [⁸⁹Zr]Zr-hCD103.Fab01A and [⁶⁸Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET.

Fan X, Ważyńska MA, Kol A, Perujo Holland N, Fernandes B, van Duijnhoven SMJ, Plat A, van Eenennaam H, Elsinga PH, Nijman HW, de Bruyn M. Fan X, et al. Among authors: nijman hw. EJNMMI Res. 2023 Nov 20;13(1):100. doi: 10.1186/s13550-023-01043-9. EJNMMI Res. 2023. PMID: 37985555 Free PMC article.

2

Size matters: Survival benefit conferred by intratumoral T cells is dependent on surgical outcome, treatment sequence and T cell differentiation.

Wouters MC, Komdeur FL, de Bruyn M, Nijman HW. Wouters MC, et al. Among authors: nijman hw. Oncoimmunology. 2016 Jan 4;5(5):e1122863. doi: 10.1080/2162402X.2015.1122863. eCollection 2016 May. Oncoimmunology. 2016. PMID: 27467933 Free PMC article.

3

The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment.

Versluis MAC, Marchal S, Plat A, de Bock GH, van Hall T, de Bruyn M, Hollema H, Nijman HW. Versluis MAC, et al. Among authors: nijman hw. Eur J Cancer. 2017 Nov;86:285-295. doi: 10.1016/j.ejca.2017.09.008. Epub 2017 Oct 20. Eur J Cancer. 2017. PMID: 29059634

4

L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition.

Versluis M, Plat A, de Bruyn M, Matias-Guiu X, Trovic J, Krakstad C, Nijman HW, Bosse T, de Bock GH, Hollema H. Versluis M, et al. Among authors: nijman hw. Virchows Arch. 2018 Nov;473(5):591-598. doi: 10.1007/s00428-018-2444-8. Epub 2018 Aug 23. Virchows Arch. 2018. PMID: 30140948 Free article.

5

Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survival.

Vlaming M, Bilemjian V, Freile JÁ, Melo V, Plat A, Huls G, Nijman HW, de Bruyn M, Bremer E. Vlaming M, et al. Among authors: nijman hw. Front Immunol. 2022 Oct 21;13:1031746. doi: 10.3389/fimmu.2022.1031746. eCollection 2022. Front Immunol. 2022. PMID: 36341460 Free PMC article.

6

Development of ⁸⁹Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration.

Kol A, Fan X, Wazynska MA, van Duijnhoven SMJ, Giesen D, Plat A, Van Eenennaam H, Elsinga PH, Nijman HW, de Bruyn M. Kol A, et al. Among authors: nijman hw. J Immunother Cancer. 2022 Dec;10(12):e004877. doi: 10.1136/jitc-2022-004877. J Immunother Cancer. 2022. PMID: 36600560 Free PMC article.

7

Prediction of recurrence risk in endometrial cancer with multimodal deep learning.

Volinsky-Fremond S, Horeweg N, Andani S, Barkey Wolf J, Lafarge MW, de Kroon CD, Ørtoft G, Høgdall E, Dijkstra J, Jobsen JJ, Lutgens LCHW, Powell ME, Mileshkin LR, Mackay H, Leary A, Katsaros D, Nijman HW, de Boer SM, Nout RA, de Bruyn M, Church D, Smit VTHBM, Creutzberg CL, Koelzer VH, Bosse T. Volinsky-Fremond S, et al. Among authors: nijman hw. Nat Med. 2024 May 24. doi: 10.1038/s41591-024-02993-w. Online ahead of print. Nat Med. 2024. PMID: 38789645

8

Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters.

Versluis MA, de Jong RA, Plat A, Bosse T, Smit VT, Mackay H, Powell M, Leary A, Mileshkin L, Kitchener HC, Crosbie EJ, Edmondson RJ, Creutzberg CL, Hollema H, Daemen T, de Bock GH, Nijman HW. Versluis MA, et al. Among authors: nijman hw. Br J Cancer. 2015 Sep 1;113(5):786-93. doi: 10.1038/bjc.2015.268. Epub 2015 Jul 28. Br J Cancer. 2015. PMID: 26217922 Free PMC article.

9

Noninvasive monitoring of cancer therapy induced activated T cells using [¹⁸F]FB-IL-2 PET imaging.

Hartimath SV, Draghiciu O, van de Wall S, Manuelli V, Dierckx RA, Nijman HW, Daemen T, de Vries EF. Hartimath SV, et al. Among authors: nijman hw. Oncoimmunology. 2016 Nov 18;6(1):e1248014. doi: 10.1080/2162402X.2016.1248014. eCollection 2017. Oncoimmunology. 2016. PMID: 28197364 Free PMC article.

10

Therapy-Induced Changes in CXCR4 Expression in Tumor Xenografts Can Be Monitored Noninvasively with N-[¹¹C]Methyl-AMD3465 PET.

Hartimath SV, Draghiciu O, Daemen T, Nijman HW, van Waarde A, Dierckx RAJO, de Vries EFJ. Hartimath SV, et al. Among authors: nijman hw. Mol Imaging Biol. 2020 Aug;22(4):883-890. doi: 10.1007/s11307-019-01447-x. Mol Imaging Biol. 2020. PMID: 31802362 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

197 results

Search Page